Pediatric Mycoplasma Pneumoniae Infections in Ganzhou, China (2017-2024)

Guihua Lai's research dataset analyzes the impact of COVID-19 on Mycoplasma pneumoniae infections in children with community-acquired pneumonia. It contains aggregated results from 27,369 hospitalized pediatric patients over an eight-year period from 2017 to 2024. The study compares MP positivity rates, seasonality, age distribution, and disease severity across pre-pandemic, non-pharmaceutical intervention, and post-intervention phases.

Use Cases

• Analyze changes in MP positivity rate across pandemic phases using the aggregated patient counts and percentages.
• Model shifts in seasonal patterns by comparing spring positivity rates between Phase I and Phase III.
• Investigate age-specific susceptibility by examining positivity rates for the 1-3, 4-6, and 7-10 years age groups across different phases.
• Assess clinical severity by comparing proportions of severe pneumonia and rates of mechanical ventilation between study periods.

Strengths

• Aggregated data from 27,369 pediatric CAP patient records provides a substantial sample.
• Clear temporal coverage from 2017 to 2024 allows for pre- and post-pandemic comparison.
• Analysis includes specific statistical results (e.g., χ²=505.33, p<0.001) for key findings.

Limitations

• The 32.0 KB size indicates the dataset contains only summary statistics, not individual patient-level records.
• Geographic scope is limited to a single city (Ganzhou, China), limiting generalizability.
• The dataset's structure is described within a DOC file, which may complicate direct computational analysis.

Provenance

Source

figshare, authored by Guihua Lai.

Collection Method

Retrospective analysis of hospitalized pediatric CAP patient records.

Time Range

2017 to 2024.

Freshness

Data covers up to 2024 and was last updated on the platform in April 2026.

Geography

Ganzhou, China.